Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Antigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma
David Ramos-Barbón, … , Elizabeth D. Fixman, James G. Martin
David Ramos-Barbón, … , Elizabeth D. Fixman, James G. Martin
Published June 1, 2005
Citation Information: J Clin Invest. 2005;115(6):1580-1589. https://doi.org/10.1172/JCI19711.
View: Text | PDF
Research Article Pulmonology

Antigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma

  • Text
  • PDF
Abstract

Airway smooth muscle (ASM) growth contributes to the mechanism of airway hyperresponsiveness in asthma. Here we demonstrate that CD4+ T cells, central to chronic airway inflammation, drive ASM remodeling in experimental asthma. Adoptive transfer of CD4+ T cells from sensitized rats induced an increase in proliferation and inhibition of apoptosis of airway myocytes in naive recipients upon repeated antigen challenge, which resulted in an increase in ASM mass. Genetically modified CD4+ T cells expressing enhanced GFP (EGFP) were localized by confocal microscopy in juxtaposition to ASM cells, which suggests that CD4+ T cells may modulate ASM cell function through direct cell-cell interaction in vivo. Coculture of antigen-stimulated CD4+ T cells with cell cycle–arrested ASM cells induced myocyte proliferation, dependent on T cell activation and direct T cell–myocyte contact. Reciprocally, direct cell contact prevented postactivation T cell apoptosis, which suggests receptor-mediated T cell–myocyte crosstalk. Overall, our data demonstrate that activated CD4+ T cells drive ASM remodeling in experimental asthma and suggest that a direct cell-cell interaction participates in CD4+ T cell regulation of myocyte turnover and induction of remodeling.

Authors

David Ramos-Barbón, John F. Presley, Qutayba A. Hamid, Elizabeth D. Fixman, James G. Martin

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
CD4+ T cell activation, retroviral transduction, and adoptive transfer o...
CD4+ T cell activation, retroviral transduction, and adoptive transfer of inflammatory responses. Total cell populations from sensitized lymph nodes were cultured with OVA and subsequently transduced with retroviruses encoding EGFP. (A) We identified the transduced cell population using EGFP as a selectable marker. (C) The EGFP+ cells exclude propidium iodide (PI) and are thus viable. (E) The majority of the EGFP+ cells are CD4+ T cells, which demonstrates selective transduction of this cell type. (B, D, and F) Stimulation with OVA led to progressive enrichment of CD4+ T cells in the cultured population as well as upregulation of CD4 expression from day 1 to day 6 (compare B and D). The data from B and D are presented as histograms in F. The thin line represents the CD4 distribution in the lymph node cell population as harvested from donors on day 1. The thick line represents the CD4 distribution following lymph node culture with OVA for 6 days. The dotted line represents the isotype control. (G) Following transduction, EGFP+ cells were sorted by FACS, and 2 × 105 cells were transferred into unsensitized recipients that were subsequently airway challenged with OVA. Controls were recipients of EGFP+ cells challenged with vehicle or naive animals challenged with OVA. In recipients of EGFP+ cells, the absolute number of lung lymphocytes was increased 5-fold, and the absolute number of BAL leukocytes was increased 3-fold compared with controls. Data are from 2 independent experiments. Error bars represent range.

Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts